Kim Kyung-Soo, Hong Sangmo, Han Kyungdo, Park Cheol-Young
Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
J Lipid Atheroscler. 2022 Jan;11(1):73-83. doi: 10.12997/jla.2022.11.1.73. Epub 2021 Aug 18.
To validate the criteria for the extreme risk category for atherosclerotic cardiovascular disease (ASCVD).
An observational cohort study of 35,464 individuals with established ASCVD was performed using the National Health Information Database. Incident myocardial infarction (MI), ischemic stroke, and death in patients with established ASCVD was investigated to validate the criteria for the extreme risk category of ASCVD defined as the presence of diabetes mellitus (DM), chronic kidney disease (CKD), and history of premature ASCVD.
Among 35,464 patients, 77.97% of them were classified into the extreme risk group of ASCVD. A total of 28.10%, 39.61%, and 32.12% had DM, CKD, and a history of premature ASCVD, respectively. During a mean follow-up of 8.39 years, MI, ischemic stroke, and all-cause death were found in 3.87%, 8.51%, and 23.98% of participants, respectively. In multivariate analysis, patients with DM had higher risk for MI (hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.45-1.81), ischemic stroke (HR, 1.39; 95% CI, 1.29-1.50), and all-cause death (HR, 1.52; 95% CI, 1.45-1.59) than those without DM. Patients with CKD had 1.56 times higher risk for MI, 1.12 times higher risk for ischemic stroke, and 1.34 times higher risk for death than those without CKD. However, the risk for MI, ischemic stroke, and all-cause death was not different between patients with and without a history of premature ASCVD.
DM and CKD, but not a history of premature ASCVD, could be considered as reasonable criteria of an extreme risk for ASCVD.
验证动脉粥样硬化性心血管疾病(ASCVD)极高风险类别的标准。
利用国家健康信息数据库对35464例已确诊ASCVD的个体进行了一项观察性队列研究。对已确诊ASCVD患者的新发心肌梗死(MI)、缺血性卒中及死亡情况进行调查,以验证定义为患有糖尿病(DM)、慢性肾脏病(CKD)及过早发生ASCVD病史的ASCVD极高风险类别的标准。
在35464例患者中,77.97%被归类为ASCVD极高风险组。分别有28.10%、39.61%和32.12%的患者患有DM、CKD及过早发生ASCVD病史。在平均8.39年的随访期间,分别有3.87%、8.51%和23.98%的参与者发生了MI、缺血性卒中和全因死亡。多因素分析显示,与未患DM的患者相比,患DM的患者发生MI(风险比[HR],1.62;95%置信区间[CI],1.45 - 1.81)、缺血性卒中(HR,1.39;95% CI,1.29 - 1.50)及全因死亡(HR,1.52;95% CI,1.45 - 1.59)的风险更高。与未患CKD的患者相比,患CKD的患者发生MI的风险高1.56倍,发生缺血性卒中的风险高1.12倍,死亡风险高1.34倍。然而,有过早发生ASCVD病史的患者与无此病史的患者在MI、缺血性卒中和全因死亡风险方面并无差异。
DM和CKD可被视为ASCVD极高风险的合理标准,而过早发生ASCVD病史则不然。